Plasma Protein Therapeutics Market Size, Share, Growth, Report 2028
Plasma Protein Therapeutics Market By Product Type (C1 esterase Inhibitors, Albumins, Immunoglobulin, Coagulation Factors, and Others), By Application (Hereditary Angioedema, Hemophilia, Primary Immunodeficiency Disorder, Secondary Immunodeficiency, Idiopathic Thrombocytopenic, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028
Category: Pharmaceutical Report Format : PDF
Pages: 180 Report Code: ZMR-3310
Published Date: Apr-2022 Status : Published
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 24.94 Billion | USD 41.75 Billion | 6.7% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Plasma Protein Therapeutics Market, (2022 - 2028) (USD Billion)
- 2.2 Global Plasma Protein Therapeutics Market : snapshot
- Chapter 3. Global Plasma Protein Therapeutics Market - Industry Analysis
- 3.1 Plasma Protein Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing incidences of chronic diseases to foster the market growth
- 3.3 Market Restraints
- 3.3.1. Strict regulations in different countries to impede the market growth
- 3.4 Market Opportunities
- 3.4.1. High demand for Immunoglobulins (IG) to propel the market growth during the forecast period
- 3.5 Market Challenges
- 3.5.1. Unfavorable reimbursement policies to pose major challenge to market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Application
- Chapter 4. Global Plasma Protein Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Plasma Protein Therapeutics Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Plasma Protein Therapeutics Market - Product Type Analysis
- 5.1 Global Plasma Protein Therapeutics Market overview: By Product Type
- 5.1.1 Global Plasma Protein Therapeutics Market share, By Product Type, 2021 and 2028
- 5.2 C1 esterase Inhibitors
- 5.2.1 Global Plasma Protein Therapeutics Market by C1 esterase Inhibitors, 2022 - 2028 (USD Billion)
- 5.3 Albumins
- 5.3.1 Global Plasma Protein Therapeutics Market by Albumins, 2022 - 2028 (USD Billion)
- 5.4 Immunoglobulins
- 5.4.1 Global Plasma Protein Therapeutics Market by Immunoglobulins, 2022 - 2028 (USD Billion)
- 5.5 Coagulation Factors
- 5.5.1 Global Plasma Protein Therapeutics Market by Coagulation Factors, 2022 - 2028 (USD Billion)
- 5.6 Others
- 5.6.1 Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
- 5.1 Global Plasma Protein Therapeutics Market overview: By Product Type
- Chapter 6. Global Plasma Protein Therapeutics Market - Application Analysis
- 6.1 Global Plasma Protein Therapeutics Market overview: By Application
- 6.1.1 Global Plasma Protein Therapeutics Market share, By Application, 2021 and 2028
- 6.2 Hereditary Angioedema
- 6.2.1 Global Plasma Protein Therapeutics Market by Hereditary Angioedema, 2022 - 2028 (USD Billion)
- 6.3 Hemophilia
- 6.3.1 Global Plasma Protein Therapeutics Market by Hemophilia, 2022 - 2028 (USD Billion)
- 6.4 Primary Immunodeficiency Disorder
- 6.4.1 Global Plasma Protein Therapeutics Market by Primary Immunodeficiency Disorder, 2022 - 2028 (USD Billion)
- 6.5 Secondary Immunodeficiency
- 6.5.1 Global Plasma Protein Therapeutics Market by Secondary Immunodeficiency, 2022 - 2028 (USD Billion)
- 6.6 Idiopathic Thrombocytopenic
- 6.6.1 Global Plasma Protein Therapeutics Market by Idiopathic Thrombocytopenic, 2022 - 2028 (USD Billion)
- 6.7 Others
- 6.7.1 Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
- 6.1 Global Plasma Protein Therapeutics Market overview: By Application
- Chapter 7. Plasma Protein Therapeutics Market - Regional Analysis
- 7.1 Global Plasma Protein Therapeutics Market Regional Overview
- 7.2 Global Plasma Protein Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
- 7.3. North America
- 7.3.1 North America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.3.1.1 North America Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.3.1 North America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 North America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
- 7.4.1 North America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
- 7.5 North America Plasma Protein Therapeutics Market, by Application, 2022 - 2028
- 7.5.1 North America Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4.2.1 Europe Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.4.2 Europe Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 Europe Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
- 7.4.1 Europe Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
- 7.5 Europe Plasma Protein Therapeutics Market, by Application, 2022 - 2028
- 7.5.1 Europe Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.5.3.1 Asia Pacific Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.5.3 Asia Pacific Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 Asia Pacific Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
- 7.4.1 Asia Pacific Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
- 7.5 Asia Pacific Plasma Protein Therapeutics Market, by Application, 2022 - 2028
- 7.5.1 Asia Pacific Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.6.4.1 Latin America Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.6.4 Latin America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 Latin America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
- 7.4.1 Latin America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
- 7.5 Latin America Plasma Protein Therapeutics Market, by Application, 2022 - 2028
- 7.5.1 Latin America Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 7.7.5 The Middle-East and Africa Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 7.4 The Middle-East and Africa Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
- 7.4.1 The Middle-East and Africa Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
- 7.5 The Middle-East and Africa Plasma Protein Therapeutics Market, by Application, 2022 - 2028
- 7.5.1 The Middle-East and Africa Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Biotest AG
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 CSL Behring
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Grifols SA
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Octapharma USA Inc.
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Takeda Pharmaceutical Company Ltd
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Bio Products Laboratory
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Shire PLC
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Kedrion SpA
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 China Biologic Products Holdings Inc.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Baxter
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.1 Biotest AG
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Plasma Protein Therapeutics Market attractiveness, By Product Type
- 6. Global Plasma Protein Therapeutics Market attractiveness, By Application
- 7. Global Plasma Protein Therapeutics Market share by Product Type, 2022 and 2028 (USD Billion)
- 8. Global Plasma Protein Therapeutics Market by C1 esterase Inhibitors, 2022 - 2028 (USD Billion)
- 9. Global Plasma Protein Therapeutics Market by Albumins, 2022 - 2028 (USD Billion)
- 10. Global Plasma Protein Therapeutics Market by Immunoglobulins, 2022 - 2028 (USD Billion)
- 11. Global Plasma Protein Therapeutics Market by Coagulation Factors, 2022 - 2028 (USD Billion)
- 12. Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
- 13. Global Plasma Protein Therapeutics Market share by Application, 2022 and 2028 (USD Billion)
- 14. Global Plasma Protein Therapeutics Market by Hereditary Angioedema, 2022 - 2028 (USD Billion)
- 15. Global Plasma Protein Therapeutics Market by Hemophilia, 2022 - 2028 (USD Billion)
- 16. Global Plasma Protein Therapeutics Market by Primary Immunodeficiency Disorder, 2022 - 2028 (USD Billion)
- 17. Global Plasma Protein Therapeutics Market by Secondary Immunodeficiency, 2022 - 2028 (USD Billion)
- 18. Global Plasma Protein Therapeutics Market by Idiopathic Thrombocytopenic, 2022 - 2028 (USD Billion)
- 19. Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
- 20. Global Plasma Protein Therapeutics Market share, by Region, 2022 and 2028
- 21. North America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 22. Europe Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 23. Asia Pacific Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 24. Latin America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
- 25. The Middle-East and Africa Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Plasma Protein Therapeutics Market: Snapshot
- 2. Drivers of the Plasma Protein Therapeutics Market: impact analysis
- 3. North America Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 4. North America Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 5. U.S. Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 6. U.S. Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 7. Canada Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 8. Canada Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 9. Europe Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 10. Europe Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 11. Germany Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 12. Germany Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 13. France Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 14. France Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 15. U.K. Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 16. U.K. Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 17. Italy Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 18. Italy Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 19. Spain Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 20. Spain Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 21. Rest of Europe Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 22. Rest of Europe Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 23. Asia Pacific Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 25. China Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 26. China Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 27. Japan Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 28. Japan Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 29. India Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 30. India Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 31. South Korea Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 32. South Korea Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 33. South-East Asia Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 34. South-East Asia Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 35. Rest of Asia Pacific Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 36. Rest of Asia Pacific Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 37. Latin America Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 38. Latin America Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 39. Brazil Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 40. Brazil Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 41. Mexico Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 42. Mexico Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 43. Rest of Latin America Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 44. Rest of Latin America Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 45. The Middle-East and Africa Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 46. The Middle-East and Africa Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 47. GCC Countries Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 48. GCC Countries Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 49. South Africa Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 50. South Africa Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
- 51. Rest of Middle-East Africa Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 52. Rest of Middle-East Africa Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
The market is being primarily driven by the increasing incidence of over 200 life-threatening disorders that affect the neurological and immune systems, including idiopathic thrombocytopenic purpura, multifocal motor neuropathy, chronic inflammatory demyelinating polyneuropathy, and other infectious diseases such as varicella, tetanus, rabies, and hepatitis A&B. Additionally, factors such as an increase in drug discovery & development programs, growing investment in R&D activities, and increase in the number of clinical trials are propelling the market growth.
According to the Zion Market Research report, the global plasma protein therapeutics market was worth about 24.94 (USD billion) in 2021 and is predicted to grow to around 41.75 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 6.8 percent.
North America is likely to lead the global plasma protein therapeutics market during the projected period. Factors such as the rising incidence and prevalence of neurological and autoimmune diseases are driving market expansion. The United States is likely to be the region's largest market. The region's growing geriatric population further expands the patient pool, as the aged people are more susceptible to neurological diseases.
The major players that are successfully operating in the global plasma protein therapeutics market are Biotest AG, CSL Behring, Grifols SA, Octapharma USA Inc., Takeda Pharmaceutical Company Ltd, Bio Products Laboratory, Shire PLC, Kedrion SpA, China Biologic Products Holdings Inc., and Baxter, among others.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed